CO-VALSATAN® is an antihypertensive angiotensin receptor antagonist (ARA II), indicated for the treatment of essential hypertension; heart failure and post myocardial infarction.
| DCI | VALSARTAN / HCTZ |
|---|---|
| Dosage | 80/12.5 mg |
| Trade name | CO-VALSATAN® |
| Name of the originator | CO TAREG |
| Presentation | 30 tablets |
| Specialty | Cardiologie – Sartans |
